M
Mary F. Jones
Researcher at Mayo Clinic
Publications - 14
Citations - 1731
Mary F. Jones is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Viremia & Congenital cytomegalovirus infection. The author has an hindex of 11, co-authored 14 publications receiving 1622 citations.
Papers
More filters
Journal ArticleDOI
Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing
Mark J. Espy,J. R. Uhl,Lynne M. Sloan,Seanne P. Buckwalter,Mary F. Jones,Emily A. Vetter,Joseph D. Yao,Nancy L. Wengenack,Jon E. Rosenblatt,Franklin R. Cockerill,Thomas F. Smith +10 more
TL;DR: Real-time PCR assays provide sensitivity and specificity equivalent to that of conventional PCR combined with Southern blot analysis, and since amplification and detection steps are performed in the same closed vessel, the risk of releasing amplified nucleic acids into the environment is negligible.
Journal ArticleDOI
Seroconversion to Human Herpesvirus 6 following Liver Transplantation Is a Marker of Cytomegalovirus Disease
David H. Dockrell,Jose Prada,Mary F. Jones,Robin Patel,Andrew D. Badley,William S. Harmsen,Duane M. Ilstrup,Russell H. Wiesner,Ruud A.F. Krom,Thomas F. Smith,Carlos V. Paya +10 more
TL;DR: The results indicate that HHV-6 seroconversion is a marker for CMV disease after transplantation and suggest that additional studies using more sensitive diagnostic techniques are warranted to determine the relationship between HHv-6 and CMV infection after transplants.
Journal ArticleDOI
Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients.
David H. Dockrell,Julio C. Mendez,Mary F. Jones,William S. Harmsen,Duane M. Ilstrup,Thomas F. Smith,Russell H. Wiesner,Ruud A.F. Krom,Carlos V. Paya +8 more
TL;DR: Results suggest that HHV-6 seronegativity before transplantation is a valuable clinical marker that identifies patients at risk for developing fungal infection after transplantation.
Journal ArticleDOI
Quantitative Real-Time Polymerase Chain Reaction for Evaluating DNAemia due to Cytomegalovirus, Epstein-Barr Virus, and BK Virus in Solid-Organ Transplant Recipients
Thomas F. Smith,Mark J. Espy,Jayawant N. Mandrekar,Mary F. Jones,Franklin R. Cockerill,Robin Patel +5 more
TL;DR: The need for standardization of existing variables through parallel comparative and proficiency testing, uniform units for expressing results, to provide for clinical correlation with the results of these molecular assays is emphasized.
Journal ArticleDOI
Clinical comparison of the Treponema pallidum CAPTIA syphilis-G enzyme immunoassay with the fluorescent treponemal antibody absorption immunoglobulin G assay for syphilis testing.
V. W. Halling,Mary F. Jones,Jean E. Bestrom,Arlo D. Wold,Jon E. Rosenblatt,Thomas F. Smith,Franklin R. Cockerill +6 more
TL;DR: This study demonstrates that the CAPTIA IgG EIA is a reliable method for syphilis testing and that personnel performing tests which require subjective interpretation, like the FTA-ABS test, may be biased by RPR test results.